Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allo-HSCT”

324 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 324 results

Testing effectiveness (Phase 2)Study completedNCT00024466
What this trial is testing

Chemotherapy, Vaccine Therapy, and Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT07232953
What this trial is testing

Safety and Efficacy of FT14 Conditioning for Allogeneic HSCT in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukaemia (AML)Hematopoietic Stem Cell Transplant (HSCT)
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 82
Early research (Phase 1)Study completedNCT01460901
What this trial is testing

Study of Donor Derived, Multi-virus-specific, Cytotoxic T-Lymphocytes for Relapsed/Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
Children's Mercy Hospital Kansas City 5
Not applicableStudy completedNCT03829072
What this trial is testing

Cooking Education and Adapted Physical Activity in Allografted Patients

Who this might be right for
Allograft
Centre Hospitalier Universitaire de Nice 25
Not applicableStudy completedNCT04506320
What this trial is testing

Novel Drugs After Allo-HSCT in Patients With Multiple Myeloma

Who this might be right for
Multiple MyelomaStem Cell Transplant
Gruppo Italiano Trapianto di Midollo Osseo 202
Not applicableUnknownNCT01212796
What this trial is testing

Allo After Allo Stem Cell Transplantation Following Relapse After Allogeneic Transplant in Haematological Malignancies: Retrospective Results of the GETH

Who this might be right for
Allogeneic Stem Cell Transplantation
Grupo Espanol de trasplantes hematopoyeticos y terapia celular 350
Early research (Phase 1)Ended earlyNCT01551043
What this trial is testing

Allo CART-19 Protocol

Who this might be right for
Acute Lymphocytic Leukemia
University of Pennsylvania 2
Post-approval studies (Phase 4)UnknownNCT04636918
What this trial is testing

Ikervis for DED Due to GVHD Post Allo-HSCT

Who this might be right for
Leukemia (Both ALL and AML)MDS-EB-1
Singapore Eye Research Institute 40
Early research (Phase 1)Looking for participantsNCT06326008
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Donor-derived CD19 CAR Therapy Bridged Allo-HSCT and Sequential Donor-derived CD22 CAR Therapy for r/r B-ALL: a Clinical Trial

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia, in Relapse
Beijing GoBroad Hospital 48
Not applicableStudy completedNCT02867891
What this trial is testing

Sorafenib In Relapse of FMS-like Tyrosine Kinase 3 (FLT3)-Internal Tandem Duplication (ITD) AML Trial

Who this might be right for
Acute Myeloid Leukemia
Robert Zeiser 396
Testing effectiveness (Phase 2)Looking for participantsNCT07359859
What this trial is testing

Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant

Who this might be right for
Hematologic Malignancies
Memorial Sloan Kettering Cancer Center 40
Not applicableUnknownNCT06491719
What this trial is testing

A Study on Efficacy and Safety of iNK Cells for CAEBV /EBV-HLH After Allo-HSCT

Who this might be right for
CAEBV (Chronic Active Epstein-Barr Virus Infection) SyndromeEBVHemophagocytic Lymphohistiocytoses
Beijing Friendship Hospital 15
Testing effectiveness (Phase 2)Study completedNCT02661035
What this trial is testing

Allo HSCT Using RIC for Hematological Diseases

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+15 more
Masonic Cancer Center, University of Minnesota 156
Not applicableNot Yet RecruitingNCT07440654
What this trial is testing

Efficacy and Safety of Gecacitinib Hydrochloride in Prophylaxis Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelofibrosis

Who this might be right for
aGVHD Prophylaxis
Nanfang Hospital, Southern Medical University 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06438796
What this trial is testing

Blinatumomab Maintenance After Allo-HSCT

Who this might be right for
High Risk Acute Lymphoblastic Leukemia
Ruijin Hospital 59
Large-scale testing (Phase 3)UnknownNCT04216355
What this trial is testing

Low-dose AZA Combined With Short Term CAG Derived Regimen as a Bridging Treatment in Patients With Advanced MDS Prior to Allo-HSCT

Who this might be right for
MDS-EB
Fujian Medical University 20
Not applicableUnknownNCT05532826
What this trial is testing

Clinical Study of Donor EBV-CTL Infusion in Patients With CAEBV and EBV-HLH After Allo-HSCT

Who this might be right for
Chronic Active Epstein-Barr Virus InfectionVirus-Associated Hemophagocytic Syndrome
Beijing Friendship Hospital 15
Not applicableNot Yet RecruitingNCT06385808
What this trial is testing

Efficacy and Safety of MTBF Conditioning Regimen for Salvageable Allo-HSCT in the Treatment of R/R AML

Who this might be right for
Relapse LeukemiaRefractory Acute Myeloid LeukemiaConditioning+1 more
First Affiliated Hospital Xi'an Jiaotong University 37
Testing effectiveness (Phase 2)UnknownNCT06348602
What this trial is testing

Evaluation of Safety & Efficacy for the Prevention of Ocular GVHD With Ophthalmic Tacrolimus vs Cyclosporine in Allo-HSCT

Who this might be right for
Ocular Graft-versus-host Disease
Hospital Universitario Dr. Jose E. Gonzalez 60
Not applicableStudy completedNCT04342442
What this trial is testing

Identification of Novel Targetable Kinases in SR-a GvHD

Who this might be right for
Graft Versus Host Disease
University of Freiburg 24
Next Page